Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension.

Pradhan A, Bhandari M, Singh A, Vishwakarma P, Mahajan K, Perrone MA, Batta A

Open source

DOI
10.3390/life16091495
Published
2026 Sep 7
Container
Life (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life16091495,
  title = {Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension.},
  author = {Pradhan A and Bhandari M and Singh A and Vishwakarma P and Mahajan K and Perrone MA and Batta A},
  year = {2026},
  journal = {Life (Basel, Switzerland)},
  doi = {10.3390/life16091495},
  url = {https://doi.org/10.3390/life16091495}
}

RIS

TY  - JOUR
TI  - Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension.
AU  - Pradhan A
AU  - Bhandari M
AU  - Singh A
AU  - Vishwakarma P
AU  - Mahajan K
AU  - Perrone MA
AU  - Batta A
PY  - 2026
JO  - Life (Basel, Switzerland)
DO  - 10.3390/life16091495
UR  - https://doi.org/10.3390/life16091495
ER  - 

APA

A, P., M, B., A, S., P, V., K, M., MA, P., & A, B. (2026). Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension.. Life (Basel, Switzerland). https://doi.org/10.3390/life16091495

Source records